First Developed Antiviral Pgenic Silkworm Baby In India

such

India media Fibre2fashion interviewed Dr. Sharad Aga Chandra (Sharad Chandra), chairman of the Central Silk Committee (CSB) for more information about this unique antiviral pgenic silkworm.

Fibre2fashion first asks how to develop antiviral silkworms.

He replied, "develop antiviral silkworms in two ways.

The first method is the marker assisted cultivation program. The reporter confirmed that nuclear polyhedrosis virus (NPV) penetrated into the desired two varieties and made the silkworm susceptible to infection produce NPV tolerance.

Second, the pgenic silkworm can be cultivated through RNAi interference biotechnology. In this way, the reproduction of silkworm's intestines and other organs is inhibited.

The pgenic silkworm was done through our CDFD partners in Hyderabad.

In SBRL, the breeding program has been started, and these pgenes have been pferred to the two varieties needed.

In this way, the susceptible silkworm can produce virus resistance.

Next, we asked him to talk about the advantages of developing antiviral silkworm. He said: "the advantage of cultivating silkworm is that the infected silkworm babies will be able to resist the virus function, so their survival rate is high, the quality of cocoon is good, and the output of silk is improved.

In turn, the income of sericultural farmers is also improving.

Finally, he said, "this is a systematic biotechnological approach that can control silkworm diseases, especially the NPV virus, which will increase the quantity and quality of cocoons and the productivity of silk."